Evenamide

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Evenamide
Evenamide structure.png
Systematic (IUPAC) name
2-[2-(3-butoxyphenyl)ethylamino]-N,N-dimethylacetamide
Identifiers
CAS Number 1092977-61-1
ATC code None
PubChem CID: 25105689
ChemSpider 44208827
Chemical data
Formula C16H26N2O2
Molecular mass 278.38984 g/mol
  • CCCCOC1=CC=CC(=C1)CCNCC(=O)N(C)C
  • InChI=1S/C16H26N2O2/c1-4-5-11-20-15-8-6-7-14(12-15)9-10-17-13-16(19)18(2)3/h6-8,12,17H,4-5,9-11,13H2,1-3H3
  • Key:GRHBODILPPXVKN-UHFFFAOYSA-N

Evenamide (INN) (developmental code names NW-3509, NW-3509A) is a selective voltage-gated sodium channel blocker, including (and not limited to) subtypes Nav1.3, Nav1.7, and Nav1.8, that is described as an antipsychotic and is under development by Newron Pharmaceuticals as an add-on therapy for the treatment of schizophrenia.[1][2][3][4] The drug has shown efficacy in animal models of psychosis, mania, depression, and aggression.[3] It has completed phase I clinical trials, and phase II clinical trials will be commenced in the third quarter of 2015.[1]

See also

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Lua error in package.lua at line 80: module 'strict' not found.
  3. 3.0 3.1 Lua error in package.lua at line 80: module 'strict' not found.
  4. Lua error in package.lua at line 80: module 'strict' not found.

External links



<templatestyles src="Asbox/styles.css"></templatestyles>